MedTrace Logo

Therapy of Scars and Cutis Laxa With Autologous Adipose Derived Mesenchymal Stem Cells

NCT03887208 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-02-01

No results posted yet for this study

Summary

The aim of this study is to compare clinical outcomes of patients with large scars or Cutis laxa treated with injections of autologous stromal vascular fraction cells (SVF) and adipose-derived mesenchymal stem cells (ADSC).

Conditions

  • Skin
  • Scar
  • Cutis Laxa
  • Keloid
  • Cicatrix

Interventions

PROCEDURE

Laser therapy

non-ablative fractional laser therapy of skin

BIOLOGICAL

Autologous ADSC injection

Subcutaneous injection of autologous ADSC

PROCEDURE

Normal saline injection

Subcutaneous Normal saline injection

Sponsors & Collaborators

  • Timeless Chirurgia Plastyczna-Janusz Jaworowski

    collaborator UNKNOWN

  • Melitus sp. z o.o.

    collaborator UNKNOWN

  • Polish Stem Cells Bank S.A.

    collaborator UNKNOWN

  • Medical University of Warsaw

    lead OTHER

Principal Investigators

  • Maria Noszczyk-Kostrzewa, PhD · Melitus Ltd

  • Janusz R Jaworowski, PhD · Timeless Ltd

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-31
Primary Completion
2020-01-18
Completion
2020-01-18

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03887208 on ClinicalTrials.gov